Загрузка...

Diffuse pulmonary lymphangiomatosis treated with bevacizumab

Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease caused by uncontrolled lymphatic vessel proliferation resulting in respiratory dysfunction. Lymphatic vessel growth is influenced by vascular endothelial growth factor (VEGF). It has been shown that bevacizumab, a monoclonal antibody to VEG...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Respirol Case Rep
Главные авторы: Onyeforo, Ernest, Barnett, Adrian, Zagami, Debbie, Deller, David, Feather, Iain
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Ltd 2018
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260917/
https://ncbi.nlm.nih.gov/pubmed/30510764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.384
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!